The AcPET system is unique in that its massive random biased DNA library, combined with its proprietary crosslinking system, can be used to produce proteins for virtually any purpose quickly and cost effectively. These properties make it a natural choice for use by biopharmas to address the time and cost intensive Discovery phase of new biotherapeutic product development. Further, the AcPET system can be used with other DNA libraries such as antibody scaffold libraries to make antibodies that can compete, or be used in place of, antibodies in existing applications. This would provide a simple path to take advantage of the growing market for biosimilar antibody based therapeutics. The AcPET system’s ability to produce proteins for virtually any purpose in a cost and time efficient manner speak to the technology’s enormous potential to produce protein based products for treating disease and for use by bio-researchers, as well as other industries.
Enormous Potential
Enormous potential is applied to all protein markets including human medicine, animal health and manufacturing.